Company CVAbout SMS Pharmaceuticals Ltd 
SMS Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
SMS Pharmaceuticals Limited was incorporated in December, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. Its business activity is a single primary business segment of "Bulk Drugs".
Company Coordinates
Company Details
19 III Rd 71 Opp Bharatividya, Bhavan Public Sch Jubilee Hill Hyderabad Telangana : 500096
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 8.77 Cr
Number of Shares
8.77 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
27-Jun-2017
8.77
8.77
3023287
1
DeMerger
27-Jun-2017
8.77
8.77
3023287
1
DeMerger
17-Dec-2015
8.47
8.47
76186827
1
Stock Split
17-Dec-2015
8.47
8.47
76186827
1
Stock Split
25-Jul-2013
84.65
8.47
-863
10
Buy Back of Shares
25-Jul-2013
84.65
8.47
-863
10
Buy Back of Shares
24-Jul-2013
84.72
8.47
-27000
10
Buy Back of Shares
24-Jul-2013
84.71
8.47
-503
10
Buy Back of Shares
24-Jul-2013
84.66
8.47
-5000
10
Buy Back of Shares
24-Jul-2013
84.72
8.47
-27000
10
Buy Back of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
37.5976
Mutual Funds
Held by 3 Schemes (2.43%)
FIIs
Held by 7 FIIs (0.08%)
Promoter with highest holding
Ramesh Babu Potluri (20.48%)
Highest Public shareholder
Quant Mutual Fund - Quant Small Cap Fund (2.43%)
Individual Investors Holdings
26.35%
Board of Directors
Management
Designation
Remuneration
P Ramesh Babu
Chairman & Managing Director
3.81 cr
P Sarath Kumar
Independent Director
1.0 lacs
Thummala Neelaveni
Independent Director
3.1 lacs
Shravan Kudaravalli
Independent Director
3.1 lacs
Sarvepalli Srinivas
Independent Director
75.0 k
Vamsi Krishna Potluri
Executive Director
3.81 cr
Thirumalesh Tumma
Company Sec. & Compli. Officer
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drugs
436.60
86.14%
Conversion Charges
68.11
13.44%
Export Incentives
2.16
0.43%
Bulk Drugs
Bulk Drugs
Conversion Charges
Conversion Charges
Export Incentives
Export Incentives
Stock DNARevenue and Profits:
Net Sales:
173 Cr
(Quarterly Results - Dec 2024)
Net Profit:
18 Cr
Pharmaceuticals & Drugs
INR 1,728 Cr (Small Cap)
25.00
33
0.20%
0.49
10.53%
2.98
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
